Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ ERBB2 therapy.

Details

Language :

English

ISSN :

15384047

Volume :

14

Issue :

10

Database :

Complementary Index

Journal :

Cancer Biology & Therapy

Publication Type :

Academic Journal

Accession number :

91638656

Full Text :

https://doi.org/10.4161/cbt.26234